Watson Pharmaceuticals to repay $100 million in term loan borrowings

By Sara Rosenberg

New York, Aug. 18 - Watson Pharmaceuticals Inc. plans to repay $100 million of its term loan using proceeds from an $850 million senior unsecured notes offering, according to a news release.

Remaining proceeds will be used to help fund the acquisition of Arrow Group and to redeem its $575 million of contingent senior debentures due 2023.

Watson Pharmaceuticals is a Corona, Calif.-based specialty pharmaceutical company.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.